In this downloadable slideset, Everett Vokes, MD, reviews current and emerging data on immunotherapy-based strategies in the settings of first-line and progressive HNSCC.
In this downloadable slideset, Barbara Burtness, MD, discusses current evidence for the management of immune-related adverse events and ongoing developments in immunotherapy strategies for HNC.
In this downloadable slideset, Maura L. Gillison, MD, PhD, provides an overview of the rationale and biologic mechanisms behind immunotherapeutic approaches in head and neck cancer.
In this downloadable resource, Maura L. Gillison, MD, PhD highlights key points of immunotherapy in head and neck cancer, including current approved agents, management of immune-related adverse events, and a comprehensive list of current clinical trials.
Did you miss the symposium in Scottsdale? Review this on-demand simulcast of the live event as our distinguished faculty, Maura L. Gillison, MD, PhD; Barbara Ann Burtness, MD; and Everett Vokes, MD review practical guidance in integrating immunotherapy agents into therapeutic strategies to improve outcomes for patients with HNSCC.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.